Colombia — your path to First Patient In

An entire nation aligned towards healthcare reform and innovative clinical research with world-class clinics and institutions — where clinical trials can move faster, for less.

See the Evidence Start a Conversation →
The Advantage

Colombia's unique
clinical trial advantages.

A clinic in Colombia A Colombian city Bogotá, Colombia's capital A Colombian city
Enrollment
Enrollment

Patients who show up — and stay.

Patients here show up to advance science — and for a community that's for all, not for one. That's why enrollment moves and retention holds: the mission matters to them, not just the study.

Proximity

Your team's working day, not a red-eye away.

The whole country sits within continental U.S. time zones, with direct flights from both coasts. Monitors walk a site mid-week and are home for the weekend, and calls happen in business hours, on the same calendar day.

Momentum

A government clearing the path.

A new administration elected on healthcare reform is backing life sciences from the top down, and INVIMA is opening an expedited pathway for select international sponsors. The momentum is national, not local.

Economics

Economics that beat the alternatives.

Cost per patient runs well below the U.S. and Europe, and total program economics outperform Australia even after its R&D tax rebate. The savings are structural — from a health system built at scale.

The Evidence

By the numbers.

The case for Colombia, in figures — the national picture first, then a look inside its leading institutions. Every number is tagged by what it measures.

Colombia
54M
People
Twice the population of Australia, in one-seventh the landmass — and largely new to research.
Colombia
97%
Health Coverage
Near-universal insurance nationwide — continuity of care and reliable long-term follow-up.
Colombia
3
Continents of Ancestry
European, African and Indigenous American lineages braided into one population.
Colombia
20+
Years of Global-Sponsor Trials
Programs run at scale for the largest names in medicine, across decades.
Leading centers
1–2
Weeks to Ethics Review
Review boards convene weekly at top institutions, with expedited INVIMA pathways in motion.
Single site
Zero
Critical Findings
One flagship center's record across MHRA and global-sponsor audits — a site-level snapshot, not a national figure.

National figures drawn from public sources; institution-level figures verified on-site in Cali & Bogotá. Scope is tagged on each. Full dossiers available under confidentiality.

See what your next trial could look like in Colombia.

Start a Conversation →
The Infrastructure

Institutions ready to run
Phase I through III.

Colombia's research runs inside accredited academic hospitals and dedicated cancer institutes — with early-phase units, advanced-therapy handling, and certified labs already delivering the full development arc for the world's largest sponsors.

The Institutions
  • 120+ GCP-certified research centers — INVIMA-certified and compliant with FDA inspection standards, with 25+ years running global-sponsor trials.
  • Accredited academic hospitals — JCI- and CAP-credentialed university centers with dedicated research units, not clinic time borrowed part-time.
  • Dedicated cancer institutes — comprehensive oncology centers across Bogotá and Medellín — solid tumor and hematology, with on-site imaging and molecular pathology.
  • 60+ standing ethics committees — GCP-certified boards convening on regular cycles, so review doesn't wait in a queue.
Phase I–III Capability
  • The full development arc — first-in-human Phase I through pivotal Phase III, with early phase now the fastest-growing segment.
  • Advanced-therapy handling — cell and gene therapy and cancer vaccines, with −80 °C cold chains and certified laboratories.
  • Early-phase units — controlled dosing, intensive PK/PD sampling, and investigational pharmacies built for complex protocols.
  • Trial-grade data — certified central labs and hospital records mapped to 21 CFR Part 11 and ICH E6(R3) for use as source data.
Why Colombia, Why Now

Colombia is home to 54 million people — most of whom have never been offered anything beyond the standard of care.

However, their clinics and institutions have quietly run the world's most demanding trial programs for large pharmaceutical companies for decades.

A new administration — elected on healthcare reform — brings a mandate to transform the healthcare system and incentivize life sciences.

A nation that's aligned — and ready — for the clinical research and infrastructure to support your clinical trials at a speed and efficiency you won't find anywhere else.

The Timeline

First patient in ≈ 6–8 weeks.

Not the ~24 weeks (6 months) that's the global average.

Colombia
week 7 · first patient in
Global average
week 24 · ~6 months
wk 0wk 6wk 12wk 18wk 24

≈ 17 weeks sooner to first patient in.

Study startup, benchmarked. The industry figure reflects published study-startup and site-activation data — median activation around six months, with independent sites faster and academic centers slower. Colombia's ≈ 6–8 weeks assumes approvals run in parallel and sites are pre-positioned.
Sources: Applied Clinical Trials trial-initiation benchmarks; TD2 and PharmExec site-activation analyses.
The Sponsors

The world's top sponsors — are already here.

Colombia's leading institutions have run clinical programs for the most-demanding sponsors — with JCI and CAP accreditations, INVIMA GCP certification, and inspection histories from FDA and EMA without findings.

MerckMerck
RocheRoche
NovartisNovartis
PfizerPfizer
AstraZenecaAstraZeneca
SanofiSanofi
AbbVieAbbVie
Bristol Myers SquibbBristol Myers Squibb
Eli LillyEli Lilly
BiogenBiogen
TakedaTakeda
AbbottAbbott

List of companies shown above are representative of sponsors that have run or are currently running clinical programs at Colombian clinical institutions. Names and marks belong to their respective owners and are shown for identification, not endorsement.

Get in Touch

¡Buenas!
Colombia welcomes you!

Reach out to us to find out more about the leading institutions, dedicated principal investigators, and the incredible opportunity across Colombia's clinical landscape.

Let us know about your upcoming programs, priorities or even just some of your wish list items and we will get back to you immediately.

We reply within one business day — and we're glad to put a CDA in place before anything sensitive is exchanged.

Consulate General of Colombia

David Rojas Garcés

Consul · West Coast · San Francisco

Your main point of contact for sponsor introductions and institutional partnerships across Colombia.